Anna Ludovica FRACANZANI
Anna Ludovica FRACANZANI
Department of Pathophysiology and Transplantation, Fondazione Ca' Granda IRCCS Ospedale Maggiore
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes
AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ...
Hepatology 48 (3), 792-798, 2008
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ...
Hepatology 51 (4), 1209-1217, 2010
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ...
Gastroenterology 122 (2), 274-280, 2002
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association
S Fargion, A Piperno, MD Cappellini, M Sampietro, AL Fracanzani, ...
Hepatology 16 (6), 1322-1326, 1992
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target
P Dongiovanni, AL Fracanzani, S Fargion, L Valenti
Journal of hepatology 55 (4), 920-932, 2011
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study
L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ...
Official journal of the American College of Gastroenterology| ACG 102 (6 …, 2007
HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease
L Valenti, AL Fracanzani, E Bugianesi, P Dongiovanni, E Galmozzi, ...
Gastroenterology 138 (3), 905-912, 2010
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
S Fargion, M Mattioli, AL Fracanzani, M Sampietro, D Tavazzi, P Fociani, ...
The American journal of gastroenterology 96 (8), 2448-2455, 2001
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease
AL Fracanzani, D Conte, M Fraquelli, E Taioli, M Mattioli, A Losco, ...
Hepatology 33 (3), 647-651, 2001
Carotid artery intima-media thickness in nonalcoholic fatty liver disease
AL Fracanzani, L Burdick, S Raselli, P Pedotti, L Grigore, G Santorelli, ...
The American journal of medicine 121 (1), 72-78, 2008
Patatin‐like phospholipase domain‐containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C
L Valenti, MG Rumi, E Galmozzi, A Aghemo, B Del Menico, S De Nicola, ...
Hepatology 53 (3), 791-799, 2011
Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis
S Fargion, C Mandelli, A Piperno, B Cesana, AL Fracanzani, M Fraquelli, ...
Hepatology 15 (4), 655-659, 1992
Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development
M Borzio, S Fargion, F Borzio, AL Fracanzani, AM Croce, T Stroffolini, ...
Journal of hepatology 39 (2), 208-214, 2003
Nonalcoholic fatty liver disease and vascular disease: state-of-the-art
S Fargion, M Porzio, AL Fracanzani
World journal of gastroenterology: WJG 20 (37), 13306, 2014
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P Dongiovanni, L Valenti, R Rametta, AK Daly, V Nobili, E Mozzi, ...
Gut 59 (2), 267-273, 2010
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
M Sampietro, A Piperno, L Lupica, C Arosio, A Vergani, N Corbetta, ...
Hepatology 27 (1), 181-184, 1998
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20